337 related articles for article (PubMed ID: 25119341)
21. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy.
Tietze JK; Wilkins DE; Sckisel GD; Bouchlaka MN; Alderson KL; Weiss JM; Ames E; Bruhn KW; Craft N; Wiltrout RH; Longo DL; Lanier LL; Blazar BR; Redelman D; Murphy WJ
Blood; 2012 Mar; 119(13):3073-83. PubMed ID: 22251483
[TBL] [Abstract][Full Text] [Related]
22. CD4+ T cell regulation of CD25 expression controls development of short-lived effector CD8+ T cells in primary and secondary responses.
Obar JJ; Molloy MJ; Jellison ER; Stoklasek TA; Zhang W; Usherwood EJ; Lefrançois L
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):193-8. PubMed ID: 19966302
[TBL] [Abstract][Full Text] [Related]
23. Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer.
Guo Z; Wang H; Meng F; Li J; Zhang S
J Transl Med; 2015 Jul; 13():247. PubMed ID: 26219551
[TBL] [Abstract][Full Text] [Related]
24. Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.
Church SE; Jensen SM; Antony PA; Restifo NP; Fox BA
Eur J Immunol; 2014 Jan; 44(1):69-79. PubMed ID: 24114780
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
[TBL] [Abstract][Full Text] [Related]
26. Solid Tumor Microenvironment Can Harbor and Support Functional Properties of Memory T Cells.
Sullivan PM; Reed SJ; Kalia V; Sarkar S
Front Immunol; 2021; 12():706150. PubMed ID: 34867942
[TBL] [Abstract][Full Text] [Related]
27. CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.
Isogawa M; Chung J; Murata Y; Kakimi K; Chisari FV
PLoS Pathog; 2013; 9(7):e1003490. PubMed ID: 23853599
[TBL] [Abstract][Full Text] [Related]
28. Suppressor of cytokine signaling 1 regulates IL-15 receptor signaling in CD8+CD44high memory T lymphocytes.
Ilangumaran S; Ramanathan S; La Rose J; Poussier P; Rottapel R
J Immunol; 2003 Sep; 171(5):2435-45. PubMed ID: 12928391
[TBL] [Abstract][Full Text] [Related]
29. The poststimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness).
Tham EL; Mescher MF
J Immunol; 2002 Aug; 169(4):1822-8. PubMed ID: 12165505
[TBL] [Abstract][Full Text] [Related]
30. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
31. CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.
Dias P; Giannoni F; Lee LN; Han D; Yoon S; Yagita H; Azuma M; Sarawar SR
J Virol; 2010 Aug; 84(16):8241-9. PubMed ID: 20534854
[TBL] [Abstract][Full Text] [Related]
32. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
33. Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells.
Feau S; Arens R; Togher S; Schoenberger SP
Nat Immunol; 2011 Jul; 12(9):908-13. PubMed ID: 21804558
[TBL] [Abstract][Full Text] [Related]
34. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
Hu Z; Molloy MJ; Usherwood EJ
Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
[TBL] [Abstract][Full Text] [Related]
35. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
36. IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype.
Casey KA; Mescher MF
J Immunol; 2007 Jun; 178(12):7640-8. PubMed ID: 17548600
[TBL] [Abstract][Full Text] [Related]
37. Activation of naive and memory T cells by interleukin-15.
Kanegane H; Tosato G
Blood; 1996 Jul; 88(1):230-5. PubMed ID: 8704178
[TBL] [Abstract][Full Text] [Related]
38. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells.
West EE; Jin HT; Rasheed AU; Penaloza-Macmaster P; Ha SJ; Tan WG; Youngblood B; Freeman GJ; Smith KA; Ahmed R
J Clin Invest; 2013 Jun; 123(6):2604-15. PubMed ID: 23676462
[TBL] [Abstract][Full Text] [Related]
39. T-cell help dependence of memory CD8+ T-cell expansion upon vaccinia virus challenge relies on CD40 signaling.
Bedenikovic G; Crouse J; Oxenius A
Eur J Immunol; 2014 Jan; 44(1):115-26. PubMed ID: 24108445
[TBL] [Abstract][Full Text] [Related]
40. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
